SPONSOR
Changchun GeneScience Pharmaceutical Co., Ltd.
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 4
Conditions studied: SafetyTolerabilityGenSci098Thyroid Eye Disease (TED)Adult Growth Hormone DeficiencyShort Bowel Syndrome (SBS) in AdultsHealthy VolunteersPostmenopause
Changchun GeneScience Pharmaceutical Co., Ltd. is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Safety, Tolerability, GenSci098, Thyroid Eye Disease (TED).
The trial portfolio spans Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Changchun GeneScience Pharmaceutical Co., Ltd.
How many clinical trials has Changchun GeneScience Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Changchun GeneScience Pharmaceutical Co., Ltd., of which 5 are actively recruiting participants. These trials cover conditions including Safety, Tolerability, GenSci098. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Changchun GeneScience Pharmaceutical Co., Ltd. research focus on?
Changchun GeneScience Pharmaceutical Co., Ltd. clinical trials span Safety, Tolerability, GenSci098, Thyroid Eye Disease (TED), Adult Growth Hormone Deficiency, and additional conditions. The research pipeline includes Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Changchun GeneScience Pharmaceutical Co., Ltd. clinical trial?
To participate in a Changchun GeneScience Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Changchun GeneScience Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Changchun GeneScience Pharmaceutical Co., Ltd.
NCT06569758 Phase 1
Recruiting
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
Safety
NCT07016802 Phase 1
Recruiting
A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
Safety
NCT07691125 Phase 4
Recruiting
Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome
Short Bowel Syndrome (SBS) in Adults
NCT07476586 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants
Healthy Volunteers
NCT07534176 Phase 1
Recruiting
To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets .
Postmenopause
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology